Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

In Vivo Engineering of Therapeutic Cells Summit

Evvnt Promotion / evvnt
-
12.07.2022 - 14.07.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 08:00 - 17:30
 
Temi della conferenza
Join the In Vivo Engineering of Therapeutic Cells Summit to Discover the Future of Cell and Gene Therapy!

In vivo gene engineering is fast becoming known as the future of cell and gene therapy with incredible amounts of investment seen in 2021, including the recent Moderna and Metagenomi collaboration alongside the partnership between Abintus Bio and MSKCC, and Tidal acquisition by Sanofi.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Adrian Bot, Chief Scientific Officer and Executive Vice President of R and D, Capstan Therapeutics, Andy Scharenberg, Chief Executive Officer, Umoja Biopharma, Cory Bentley, Co-Founder & Senior Vice President of R and D, Abintus Bio & more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1038825-1?pid=4832
Mr. In Vivo Engineering of Therapeutic Cells Summit
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developers (Earlybird rates and workshops available): USD 2999.0, Academic (Earlybird rates and workshops available): USD 2599.0, Service Providers (Earlybird rates and workshops available): USD 3599.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Swiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzÄrztekammer für WienÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltAlumni Club Medizinische Universität WiennewTree